Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Thoracic 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 2Lung Neoplasms 1Hematologic Neoplasms 1Heart Failure 1Cytokine Release Syndrome 1Atrial Fibrillation 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Metoprolol × Clear all
NCT04082910 2022-04-13

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Chinese PLA General Hospital

Phase 1/2 Unknown
30 enrolled
Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms

NCT02269696 2018-03-22

The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients

Kuopio University Hospital

Phase 3 Withdrawn
Breast

Breast Neoplasms

NCT01434134 2014-10-22

PRADA

University Hospital, Akershus

Phase 2 Completed
130 enrolled
Breast

Breast Neoplasms, Heart Failure

NCT01281787 2014-06-18

PRESAGE

European Institute of Oncology

Phase 3 Completed
320 enrolled
Thoracic

Atrial Fibrillation, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡